chrisvoncsefalvay/vaers-outcomes huggingface dataset:
RECEIVED 4TH VACCINE (2ND BOOSTER) BEFORE ELIGIBLE. NO ADVERSE EFFECTS REPORTED
Flu like symptoms, aching  and fever 99.5     So far just the first day
already expired since 23Mar2021; sore arm; taste of food is different; hasn't felt well for awhile; feels tired but not like before; dizziness after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile) and DIZZINESS (dizziness after the first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Reported.  Concomitant products included IBUPROFEN for Headache, OXCARBAZEPINE (OXTELLAR XR), TOPIRAMATE, LISINOPRIL, HYDROCHLOROTHIAZIDE and LORAZEPAM for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness after the first dose). On 04-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different) and MALAISE (hasn't felt well for awhile). 04-May-2021, the patient experienced FATIGUE (feels tired but not like before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile), DIZZINESS (dizziness after the first dose) and FATIGUE (feels tired but not like before) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information  was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non-Significant Follow-up
HEADACHE; PAIN IN THE HEEL; FEVER; PAIN AT INJECTION SITE; FELLING UNCOORDINATED; PAIN RADIATING TO THE NECK; DIZZY; SHOOTING PAIN IN EAR; PAIN IN THE ANKLE; MUSCLE PAIN; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included osteo-arthritis, fibromyalgia, kidney stone, penicillin allergy, ibuprofen allergy, corticosteroid allergy and erythromycin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 14:00 at left arm for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced dizzy. On 2021, the subject experienced shooting pain in ear. On 2021, the subject experienced pain in the ankle. On 2021, the subject experienced muscle pain. Treatment medications included: acetylsalicylic acid. On 25-MAR-2021, the subject experienced felling uncoordinated. On 25-MAR-2021, the subject experienced pain radiating to the neck. On 25-MAR-2021, the subject experienced pain at injection site. On 25-MAR-2021 20:00, the subject experienced fever. On 31-MAR-2021, the subject experienced pain in the heel. On 02-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizzy, felling uncoordinated, and fever, had not recovered from headache, and the outcome of pain at injection site, pain in the heel, pain in the ankle, muscle pain, shooting pain in ear and pain radiating to the neck was not reported. This report was non-serious.
Adverse event: Vaccine administered 2 days after beyond use date and less effective. Treatment: Pt is receiving another dose in office as recommended by Pfizer.
Varicella adm 1-15-16. Client reports that developed chicken pox blister-like rash to all over body. Denies any fever since vaccine. C/O nausea and headache 2 days ago. Went to Dr and was prescribed acyclovir: (client had never been vaccinated as child).
Patient became dizzy 10-15 min after vaccine. He started to complain that his lips and tongue and felt numb and swollen. His vitals were normal. He had no swelling that was noted on exam. He received 50mg of BENADRYL. After 20 min he felt fine and was d/c' d home. He had no hives, cough or wheezing.
hearing deficit / hearing loss; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A 72-year-old patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 3 (BOOSTER), SINGLE, verbatim: I received your Covid "vaccine" in 2 doses, as well as 2 boosters/I have always experienced very acute hearing), for COVID-19 immunization, reaction(s): "hearing deficit / hearing loss"; Bnt162b2 (DOSE 2, SINGLE, verbatim: I received your Covid "vaccine" in 2 doses, as well as 2 boosters/I have always experienced very acute hearing), for COVID-19 immunization, reaction(s): "hearing deficit / hearing loss"; Bnt162b2 (DOSE 1, SINGLE, verbatim: I received your Covid "vaccine" in 2 doses, as well as 2 boosters/I have always experienced very acute hearing), for COVID-19 immunization, reaction(s): "hearing deficit / hearing loss".  The following information was reported: DEAFNESS (medically significant), outcome "unknown", described as "hearing deficit / hearing loss".  Clinical course: It was reported that patient received Covid "vaccine" in 2 doses, as well as 2 boosters. Patient was 72. Patient had always experienced very acute hearing & had no family history of hearing loss.That past year patient's grandchildren brought to his/her attention, Pt. had a hearing deficit. After an ear examination & hearing test by 2 doctors, patient was then a prime candidate for hearing aids. In retrospect patient believed he/she might had his/her hearing loss due to the boosters. No one could be sure. Patient felt this information was important for the records.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
10/6/21 pcp office visit    Has some concerns about symptoms after his recent COVID-19 vaccination COVID vaccination history:  1/30 had Moderna dose #1 - a week later had dizziness but no chills or fever, lasted about a week 2/27 had Moderna dose #2 - a week later had mild myalgia perhaps 2-3 days  9/7 had Moderna dose #3 - about a week later, had stiffness and severe muscle aches for a few days, then went away   Yesterday he started with proximal muscle weakness and aches again, but much worse For example this morning could not lift his thigh without pulling it up with his arms Had to grab on to something to pull himself up this morning Achy from shoulders to upper arm   Went to chiropractor this morning who noticed he was stiff  Took 2 Advil and feels markedly better than he did this morning   Has his physical with Dr. every year, this has been a tradition for him for decades and plans to continue to do so until he should retire   He needs a refill of his alprazolam which he primarily uses to help sleep at night   He sees a cardiologist for monitoring of his coronary artery disease  Review of Systems
Numbness under right arm; Numbness on left side of mastectomy scar; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPOAESTHESIA (Numbness under right arm) and SCAR (Numbness on left side of mastectomy scar) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Blood pressure.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE HYPOAESTHESIA (Numbness under right arm) and SCAR (Numbness on left side of mastectomy scar). At the time of the report, INJECTION SITE HYPOAESTHESIA (Numbness under right arm) and SCAR (Numbness on left side of mastectomy scar) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported was blood pressure medication.  On 10 Mar 2021 the patient received the second dose of the Moderna covid-19 vaccine.  No treatment medication information was provided.
Mild flu-like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Mild flu-like symptoms) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 prophylaxis.     Patient had allergy with unknown drug.  The patient's past medical history included Breast cancer. Concurrent medical conditions included Type 2 diabetes mellitus and Hyperlipidemia. Concomitant products included METFORMIN, ROSUVASTATIN, ANASTROZOLE, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN C [ASCORBIC ACID], CALCIUM, COLECALCIFEROL (VITAMIN D3 CALCIUM), FISH OIL, VITAMIN E [VITAMIN E NOS], TRAMETES VERSICOLOR MYCELIUM (TURKEY TAIL) and MEDIUM-CHAIN TRIGLYCERIDES (MCT) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced INFLUENZA LIKE ILLNESS (Mild flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Mild flu-like symptoms) had resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, Batch No: 028L20A. On 5-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, Batch No: 039F21A. On 10-Oct-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, Batch No: 026F22A. Location of injection for all the dosage was Arm Left. On 28-Dec-2022, patient received Paxlovid for the treatment of COVID-19. On 1-Jan-2023, patient discontinued the treatment with Paxlovid. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. No treatment information was provided.
Persistent mouth ulcers; swollen gums; lymph node pain in neck; throat pain; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 26Feb2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 05Feb2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 01Mar2021, the patient experienced persistent mouth ulcers, swollen gums, lymph node pain in neck and throat pain. The events resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of the events included treatment with unspecified steroids and antibiotics. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event persistent mouth ulcers, swollen gums, lymph node pain in neck, throat pain was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Lymph nodes swollen, chest area swollen, left side of torso swollen, chest pain, entire left side of torso pain, left arm pain, fatigue, shortness of breath,
Pvcs exasperated post injection. Have them occasionally but post vaccine much more in quantity. Significantly more.; Also back and joint pain after bothbinjections; Also back and joint pain after bothbinjections; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included non-alcoholic steatohepatitis (nash), type 2 diabetes mellitus, and premature ventricular contractions. The patient previously had sulfa and experienced sulfonamide allergy. Concomitant medications taken within two weeks prior to vaccination included losartan potassium (LOSARTIN), valaciclovir hydrochloride (VALTREX), omeprazole (MANUFACTURER UNKNOWN), vitamin b complex (B-COMPLEX), krill oil (KRILLA) and vitamin d nos (VITAMIN D) (reported as d), all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patients premature ventricular contractions (Pvcs) exasperated post injection. The patient has had them occasionally but post vaccine much more in quantity. Significantly more. On 08Apr2021, the patient also experienced back and joint pain after both injections. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events premature ventricular contractions (Pvcs) exasperated post injection, also back and joint pain after both injections was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
on the day of the shot ,i felt fine until the evening.in pm i started execising my right arm more vigorously than i had during the day-then i started to feel light headed and my arm started to hurt quite a bit.it was still sore the next day,but gradually the pain subsided over the next 2 days.suddenly on appx thursday,march 11,i noticed a large red lump on my arm (about the size of 1/2 an egg) at the injection site-it was painful again(although not as bad as the first time),and also itchy.this lasted another day or 2,,and now it is just mildly itchy
pt recv vax 5NOV97 & 14NOV97 exp general aches, lymphadenopathy, general joint discomfort & fatigue;16NOV97 pt devel painful post auricular & cervical nodules;17NOV(7 pt devel a kin rash on face & trunk;pt recovered;
Hives occurred about 7 1/2 hours after injection. Extreme itching. I took 2 OTC Diphenhydramine Hydrochloride 25 mg tablets and used 1% hydrocortisone cream. Hives went away and itching stopped. However I continued to have out breaks for the next 8 days, which would subside by using the tablets and cream.
This non-serious spontaneous case, initially received from other non-health professional on 13-Nov-2018, concerns a 67-year-old, elderly patient of unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 Celsius. On 12-Oct-2018, the patient was administered FLUAD (TIV) [batch number 250795, dose, route of administration, anatomical location and expiry date: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805524 was crossed linked to original cases 201804863 due to same reporter.
After 4-6 hours of getting FLUVIRIN vaccine. Pt had following symtoms/RXN. All over body rash, Hives, swelling at injection site. Body aches, neck & back stiffness, dizziness nausea & diarrhea.
Patient received the first dose of the two part Pfizer COVID 19 vaccine series on 4/8/21 around 3PM. Patient arrives to the Emergency room on the morning of 4/9/21 with a chief complaint of "heart racing".  Patient reports her symptoms started around 7AM on 4/9/21. She reports that her heart feels like it starts beating really fast, and then will slow down, and then starts beating really fast again. She also reports that she feels short of breath and reports that she has difficulty finishing sentences due to this shortness of breath. Patient reports that she also has been having chest pain, but reports that she often has heart burn, so is unsure if this is related to that. Patient also reports that she feels generally weak and dizzy, with a headache. Patient reports all of these symptoms started around 7AM on 4/8/21.   ** At time of submission of report, patient is still admitted to emergency department and patient's current medical status is to be determined**
Mom reports, at 9 month visit, pt received vaccines and had a reaction that lasted 6-8 hours with crying, screaming and fever to 103F. Mom reports no redness/swelling at any injection site. Condition resolved by morning.
Fatigue, muscle pain, joint pain decreased appetite, fever, chills, weight loss trouble sleeping, injection site ached.
Patient received the second dose of the series one week early. Patient received at 14 days after first vaccine (first dose was 7/28/2021) instead of the recommended 21 days (should have been 8/18/2021)
This spontaneous report as received from a other health professional refers to a 5 year old male patient with seasonal allergy, mite allergy, allergy to animal, drug hypersensitivity, food allergy and mycotic allergy. On 03-JUL-2017 the patient was vaccinated with PROQUAD lot # M042500 dose 1 in the right thigh for prophylaxis (route of administration was not provided). On 04-JUL-2017, 8 hrs 30 min after onset of therapy the patient experienced large golf ball swelling on right thigh. A physician advised to apply ice to side and take BENADRYL as directed. The outcome of vaccination site swelling was reported as recovering/resolving. The causal relationship was not provided. Additional information is not expected as all relevant information has already been received.
Left hand in thumb area and Left wrist  patient reported a twinge feeling and was very warm.  Blood pressure was 126/80, pulse ox 95 and pulse 73.  Gave patient H2O and patient sat another 15 minutes.  Left with no more symptoms and vital signs were 120/78, pulse ox 94 and pulse 75
Patient reported dizziness, headache, racing heart and mild chest tightness.   Was evaluated by NP. HR in 80's. Lung sounds clear. Moved to private area for rest, water, snack. Encouraged to use his personal albuterol inhaler for his asthma. Repeat HR at his baseline 52bpm. Lungs sounds remained stable. Final pulse ox 99%. Observed for another 30 minutes. All symptoms resolved.
07/30-08/03/04: Swelling in both knees, occasional swelling of right carpal, left wrist, left ankle. Unable to bend right knee more than 90 degrees on 07/30-07/31/04. Left knee affected 08/01/04. Slight rash along right jawline. Slight fever on 08/02/04. Swelling and pain reduced by 08/03/04. Went to clinic on Saturday 07/31/04. Blood drawn-Motrin to reduce pain and swelling. Lost wages 08/02/04. Follow up: Additional swelling of right knee and pain in the index finger knuckles of both hands on 8/15/04 and 8/17/04.
Case number PHEH2015US016162 is an initial spontaneous report received from a consumer on 18 Aug 2015. This report refers to a 44 year old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly in Sep 2014. It was reported that her injection site became red, swollen and angry in Sep 2014. She was prescribed an oral and topical antibiotic. The site got better and then worse. Her ankle became red and inflamed and a steroid cream was prescribed. It was reported that later three of her children were diagnosed with ring worm and the family was treated with an oral antifungal and steroid cream. The symptoms resolved two months after vaccination in Nov 2014. The seriousness of the event was not reported, but the events ankle inflammation and redness were upgraded as medically significant based on the information available in the source documents. The causality of the events was not reported.
I feel achy, bad headache, slight cough, chills, feverish, and soreness on right arm where vaccine was administered.
This literature report with sparse information (initial receipt: 19-Aug-2011) concerns a male patient who died from Guillain-Barre syndrome after receiving influenza vaccination. Of note, the patient's daughter experienced a serious adverse event after receiving influenza vaccine (WAVES 2011029570).
9:10AM - 2nd dose of Moderna given, reviewed common s/sx and signs of severe reaction, advised to do 30 min observation, pt agreed to plan. 9:20AM - Complaints of severe bilateral arm itching.  VS taken. BP 150/92, HR 66, O2 95% RA, RR 20. 9:25AM - Diphenhydramine 25mg PO given. 9:30AM - Developed severe coughing, shortness of breath, throat swelling. O2 Sat 92% RA. Lungs sounds - clear inspiration with expiratory wheezing. Pt refused epi-pen, symptoms continued to worsen, pt agreed to receive an injection of epi. 9:37AM - Epinephrine IM 0.3mg to the right thigh given. O2 given, non-rebreather with 8L/min. 9:45AM - Pt symptoms improved, breathing easily and talking. O2 Sat 99% on O2 8L/min. 09:50AM - Paramedics arrived. 10:00AM - Paramedics took a new set of VS. BP 188/94, HR 76, RR 20, O2 Sat 99% RA. No SOB, No itching. 10:15AM - Pt left via ambulance to Hospital.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient experienced worsening left-sided facial droop, dizziness, tongue heaviness, and weakness within minutes after reciving vaccine. Vital signs within normal ranges except for blood pressure 141/06. Patient observed and monitored, diagnosed by neurology with myasthenia flare, and discharged to home ambulating independently and stable.
PATIENT RECEIVED THE DOSE AFTER MANUFACTURER RECOMMENDED FREEZER STORAGE DURATION.
SkinRash HIVES, ITCHING Narrative:  2MIN AFTER VACCINE GIVEN, EMP EXPERIENCED HIVES, ITCHING, GIVEN 25MG BENADRYL IM AND SENT TO ED. GIVEN DEPOMEDROL 80 MG IM  Other Relevant History:
Received VARIVAX 3-26; complained 3-27 arm being sore. Mother circled reaction area and by 3-28 red indurated 2x in size from 3-27. On exam 4"x4" - red indurated area. No lymphadenopathy. Given OMNICEF for cellulitis.